{"id":"W2970626564","doi":"10.1200/jco.2007.25.18_suppl.6574","title":"Cost-utility of adjuvant trastuzumab in Her-2/neu positive breast cancer: A Canadian perspective","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Trastuzumab; Cardiotoxicity; Breast cancer; Hazard ratio; Internal medicine; Oncology; Cohort; Quality-adjusted life year; Willingness to pay; Cost effectiveness; Cancer; Gynecology; Demography; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002369351,0.001245774,0.001012637,0.003318887,0.001808384,0.003836541,0.001618826,0.002647665,0.006489106],"category_scores_gemma":[0.009596327,0.0004716624,0.001652976,0.004107022,0.001052765,0.001117302,0.0010403,0.002579469,0.0003289861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1287933,"about_ca_system_score_gemma":0.122824,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9793385,"about_ca_topic_score_gemma":0.979888,"domain_scores_codex":[0.9977607,0.0007357358,0.00009352661,0.0001557108,0.0007487672,0.0005056011],"domain_scores_gemma":[0.996237,0.0008724028,0.0002253399,0.00003712738,0.002045871,0.0005822278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.002151455,0.0003614624,0.03928373,0.005392671,0.002261652,0.002768065,0.001564846,0.2801477,0.001905474,0.2332905,0.1613275,0.269545],"study_design_scores_gemma":[0.001643265,0.00124332,0.123208,0.01646796,0.004950866,0.003019623,0.008105516,0.3079494,0.00151738,0.1098802,0.4208102,0.001204324],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1780815,0.2566764,0.01211922,0.3180193,0.001554816,0.0005214182,0.02129247,0.0001228548,0.211612],"genre_scores_gemma":[0.8677442,0.1071489,0.006988324,0.005950311,0.0004825554,0.0001441669,0.002285973,0.00005033116,0.009205288],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1287933,"threshold_uncertainty_score":0.9344651,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0626734023369507,"score_gpt":0.4506877942075541,"score_spread":0.3880143918706034,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}